297 related articles for article (PubMed ID: 31040669)
1. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
[TBL] [Abstract][Full Text] [Related]
2. An Artificial Antigen-Presenting Cell Delivering 11 Immune Molecules Expands Tumor Antigen-Specific CTLs in
Zhang L; Song S; Jin X; Wan X; Shahzad KA; Pei W; Zhao C; Shen C
Cancer Immunol Res; 2019 Jul; 7(7):1188-1201. PubMed ID: 31113806
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
[TBL] [Abstract][Full Text] [Related]
4. Direct modulation of myelin-autoreactive CD4
Pei W; Wan X; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
Int J Nanomedicine; 2018; 13():3731-3750. PubMed ID: 29983566
[TBL] [Abstract][Full Text] [Related]
5. Paracrine release of IL-2 and anti-CTLA-4 enhances the ability of artificial polymer antigen-presenting cells to expand antigen-specific T cells and inhibit tumor growth in a mouse model.
Zhang L; Wang L; Shahzad KA; Xu T; Wan X; Pei W; Shen C
Cancer Immunol Immunother; 2017 Sep; 66(9):1229-1241. PubMed ID: 28501941
[TBL] [Abstract][Full Text] [Related]
6. Artificial antigen-presenting cells plus IL-15 and IL-21 efficiently induce melanoma-specific cytotoxic CD8+ CD28+ T lymphocyte responses.
Yu X; He J; Mongkhoune S; Peng Y; Xie Y; Su J; Zhou SF; Xie XX; Luo GR; Fang Y; Li X; Li X; Zhou N; Zhao YX; Lu XL
Asian Pac J Trop Med; 2013 Jun; 6(6):467-72. PubMed ID: 23711708
[TBL] [Abstract][Full Text] [Related]
7. CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.
Bruns H; Bessell C; Varela JC; Haupt C; Fang J; Pasemann S; Mackensen A; Oelke M; Schneck JP; Schütz C
Clin Cancer Res; 2015 May; 21(9):2075-83. PubMed ID: 25593301
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles Engineered as Artificial Antigen-Presenting Cells Induce Human CD4
Giang S; Horwitz DA; Bickerton S; La Cava A
Front Immunol; 2021; 12():628059. PubMed ID: 34122401
[TBL] [Abstract][Full Text] [Related]
9. On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.
Shahzad KA; Wan X; Zhang L; Pei W; Zhang A; Younis M; Wang W; Shen C
Drug Deliv; 2018 Nov; 25(1):703-715. PubMed ID: 29508634
[TBL] [Abstract][Full Text] [Related]
10. Efficient amplification of melanoma-specific CD8+ T cells using artificial antigen presenting complex.
Chang J
Exp Mol Med; 2006 Dec; 38(6):591-8. PubMed ID: 17202834
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
Rhodes KR; Green JJ
Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
[TBL] [Abstract][Full Text] [Related]
12. 4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.
Zhang H; Snyder KM; Suhoski MM; Maus MV; Kapoor V; June CH; Mackall CL
J Immunol; 2007 Oct; 179(7):4910-8. PubMed ID: 17878391
[TBL] [Abstract][Full Text] [Related]
13. Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance.
Kim J; Sinha S; Solomon M; Perez-Herrero E; Hsu J; Tsinas Z; Muro S
Biomaterials; 2017 Dec; 147():14-25. PubMed ID: 28923682
[TBL] [Abstract][Full Text] [Related]
14. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
Sunshine JC; Perica K; Schneck JP; Green JJ
Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
[TBL] [Abstract][Full Text] [Related]
15. Nanoscale artificial antigen presenting cells for T cell immunotherapy.
Perica K; De León Medero A; Durai M; Chiu YL; Bieler JG; Sibener L; Niemöller M; Assenmacher M; Richter A; Edidin M; Oelke M; Schneck J
Nanomedicine; 2014 Jan; 10(1):119-29. PubMed ID: 23891987
[TBL] [Abstract][Full Text] [Related]
16. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Tumor Metastasis by Artificial Antigen-Presenting Cells via Targeted Microenvironment Regulation and T-Cell Activation.
Lu Y; Li L; Du J; Chen J; Xu X; Yang X; Ding C; Mao C
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55890-55901. PubMed ID: 34787393
[TBL] [Abstract][Full Text] [Related]
18. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
[TBL] [Abstract][Full Text] [Related]
19. CD47-targeted bismuth selenide nanoparticles actualize improved photothermal therapy by increasing macrophage phagocytosis of cancer cells.
Guo Z; Liu Y; Zhou H; Zheng K; Wang D; Jia M; Xu P; Ma K; Cui C; Wang L
Colloids Surf B Biointerfaces; 2019 Dec; 184():110546. PubMed ID: 31606701
[TBL] [Abstract][Full Text] [Related]
20. Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.
Li H; Shao S; Cai J; Burner D; Lu L; Chen Q; Minev B; Ma W
Immunology; 2017 Nov; 152(3):462-471. PubMed ID: 28664991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
